Prostatic Neoplasms, Castration-Resistant
                             
                            
                            
                                
                            
                            
                                
                            
                            
                            
                                
                                    
                                            
	"Prostatic Neoplasms, Castration-Resistant" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, 
	MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, 
	which enables searching at various levels of specificity.
	
	
		
			
			
				Tumors or cancer of the PROSTATE which can grow in the presence of low or residual amount of androgen hormones such as TESTOSTERONE.
    
			
			
				
				
					
						| Descriptor ID | D064129 | 
					
						| MeSH Number(s) | C04.588.945.440.770.500 C12.294.260.750.500 C12.294.565.625.500 C12.758.409.750.500 | 
					
						| Concept/Terms | Prostatic Neoplasms, Castration-ResistantProstatic Neoplasms, Castration-ResistantCastration-Resistant Prostatic NeoplasmNeoplasm, Castration-Resistant ProstaticNeoplasms, Castration-Resistant ProstaticProstatic Neoplasm, Castration-ResistantProstatic Neoplasms, Castration ResistantAndrogen-Insensitive Prostatic NeoplasmsAndrogen Insensitive Prostatic NeoplasmsAndrogen-Resistant Prostatic NeoplasmsAndrogen Resistant Prostatic NeoplasmsProstatic Neoplasms, Hormone RefractoryHormone Refractory Prostatic NeoplasmsProstatic Neoplasms, Androgen-IndependentAndrogen-Independent Prostatic NeoplasmNeoplasm, Androgen-Independent ProstaticNeoplasms, Androgen-Independent ProstaticProstatic Neoplasm, Androgen-IndependentProstatic Neoplasms, Androgen IndependentProstatic Neoplasms, Androgen-InsensitiveAndrogen-Insensitive Prostatic NeoplasmNeoplasm, Androgen-Insensitive ProstaticNeoplasms, Androgen-Insensitive ProstaticProstatic Neoplasm, Androgen-InsensitiveProstatic Neoplasms, Androgen InsensitiveProstatic Neoplasms, Androgen-ResistantAndrogen-Resistant Prostatic NeoplasmNeoplasm, Androgen-Resistant ProstaticNeoplasms, Androgen-Resistant ProstaticProstatic Neoplasm, Androgen-ResistantProstatic Neoplasms, Androgen ResistantAndrogen-Independent Prostatic NeoplasmsAndrogen Independent Prostatic NeoplasmsCastration-Resistant Prostatic NeoplasmsCastration Resistant Prostatic Neoplasms
 Prostatic Cancer, Castration-ResistantProstatic Cancer, Castration-ResistantCancer, Castration-Resistant ProstaticCancers, Castration-Resistant ProstaticCastration-Resistant Prostatic CancersProstatic Cancer, Castration ResistantProstatic Cancers, Castration-ResistantAndrogen-Insensitive Prostatic CancerAndrogen Insensitive Prostatic CancerAndrogen-Resistant Prostatic CancerAndrogen Resistant Prostatic CancerProstatic Cancer, Hormone RefractoryHormone Refractory Prostatic CancerProstatic Cancer, Androgen-IndependentAndrogen-Independent Prostatic CancersCancer, Androgen-Independent ProstaticCancers, Androgen-Independent ProstaticProstatic Cancer, Androgen IndependentProstatic Cancers, Androgen-IndependentProstatic Cancer, Androgen-InsensitiveAndrogen-Insensitive Prostatic CancersCancer, Androgen-Insensitive ProstaticCancers, Androgen-Insensitive ProstaticProstatic Cancer, Androgen InsensitiveProstatic Cancers, Androgen-InsensitiveProstatic Cancer, Androgen-ResistantAndrogen-Resistant Prostatic CancersCancer, Androgen-Resistant ProstaticCancers, Androgen-Resistant ProstaticProstatic Cancer, Androgen ResistantProstatic Cancers, Androgen-ResistantAndrogen-Independent Prostatic CancerAndrogen Independent Prostatic CancerCastration-Resistant Prostatic CancerCastration Resistant Prostatic Cancer
 | 
					
				
			 
			
				Below are MeSH descriptors whose meaning is more general than "Prostatic Neoplasms, Castration-Resistant".
				
			 
			
			
				Below are MeSH descriptors whose meaning is more specific than "Prostatic Neoplasms, Castration-Resistant".
				
			 
		 
	 
 
                                        
                                            
	
	
		
			
			
					
				This graph shows the total number of publications written about "Prostatic Neoplasms, Castration-Resistant" by people in this website by year, and whether "Prostatic Neoplasms, Castration-Resistant" was a major or minor topic of these publications. 
				
					 
                    To see the data from this visualization as text, 
click here. 
                
		            | Year | Major Topic | Minor Topic | Total | 
|---|
| 2018 | 1 | 0 | 1 | 
| 2019 | 1 | 0 | 1 | 
                    To return to the timeline, 
click here.
                 
			 	
			
			
			
			
				Below are the most recent publications written about "Prostatic Neoplasms, Castration-Resistant" by people in Profiles.
						
					
								- 
								Building Predictive Models for Clinical Care-Where to Build and What to Predict? JAMA Netw Open. 2021 01 04; 4(1):e2032539. 
- 
								Transcriptomic Heterogeneity of Androgen Receptor Activity Defines a de novo low AR-Active Subclass in Treatment Naïve Primary Prostate Cancer. Clin Cancer Res. 2019 11 15; 25(22):6721-6730. 
- 
								Dissecting Prognostic From Predictive Utility: Circulating AR-V7 Biomarker Testing for Advanced Prostate Cancer. J Clin Oncol. 2019 08 20; 37(24):2182-2184. 
- 
								LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 05 01; 115(18):E4179-E4188.